immune system
• streptomycin-pretreated mice show increased susceptibility to infection with streptomycin resistant Salmonella enterica serovar Typhimurium SL1344, with significantly higher CFU levels in stool and spleen, and a more severe disease score as assessed by overall appearance, piloerection, mobility, posture, and decreased survival at 4 days post-infection (dpi) relative to wild-type controls
|
• following infection with Salmonella enterica serovar Typhimurium SL1344, all streptomycin-pretreated mice die by 4 dpi, unlike wild-type controls which die by 9 dpi
|
cellular
• following infection with Listeria monocytogenes EGDe, a strain susceptible to autophagy in primary macrophages, mutant bone-marrow-derived macrophages (BMDMs) show reduced levels of bacterial co-localization with
LC3 relative to wild-type BMDMs, suggesting impaired antibacterial autophagy
• however, no differences are observed in autophagy induced by Torin 1, an inducer of bulk autophagy
|
mortality/aging
• following infection with Salmonella enterica serovar Typhimurium SL1344, all streptomycin-pretreated mice die by 4 dpi, unlike wild-type controls which die by 9 dpi
|
homeostasis/metabolism
• following infection with Listeria monocytogenes EGDe, a strain susceptible to autophagy in primary macrophages, mutant bone-marrow-derived macrophages (BMDMs) show reduced levels of bacterial co-localization with
LC3 relative to wild-type BMDMs, suggesting impaired antibacterial autophagy
• however, no differences are observed in autophagy induced by Torin 1, an inducer of bulk autophagy
|